Wuhan YZY Biopharma Co., Ltd. (HKG:2496)
Hong Kong · Delayed Price · Currency is HKD 3.690
-0.110 (-2.89%)
Jun 24, 2026, 9:44 AM HKT
Wuhan YZY Biopharma Market Cap
Wuhan YZY Biopharma has a market cap or net worth of 715.3 million as of July 31, 2026. Its market cap has decreased by -35.49% in one year.
Market Cap
715.30M
Enterprise Value
746.12M
Revenue
74.40M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.69
ChartMarket Cap Chart
Since September 25, 2023, Wuhan YZY Biopharma's market cap has decreased from 3.09B to 715.30M, a decrease of -76.84%. That is a compound annual growth rate of -40.15%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 715.30M | -53.99% |
| Dec 31, 2025 | 1.55B | -3.14% |
| Dec 31, 2024 | 1.61B | -6.97% |
| Dec 29, 2023 | 1.73B | -44.13% |
| Sep 25, 2023 | 3.09B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CANbridge Pharmaceuticals | 1.18B |
| Cloudbreak Pharma | 988.14M |
| Sunho Biologics | 970.43M |
| Cutia Therapeutics | 850.28M |
| Kintor Pharmaceutical | 839.48M |
| Brii Biosciences | 678.50M |
| JW (Cayman) Therapeutics Co. | 653.49M |
| Shanghai Bio-heart Biological Technology | 552.56M |